TOL-463 Phase 2 Study for Vaginitis

Clinical trial NCT02866227 · COMPLETED

Trial details

NCT number: NCT02866227
Sponsor: Toltec Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bacterial Vaginosis Vulvovaginal Candidiasis

Start date: 2016-07-15
Primary completion: 2017-06-10
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.